A view from the Center

Deloitte Center
for Health Solutions

Filter by category or month:

Staying calm in the presence of a Zika virus surge

by Andrew Wiesenthal, MD, SM, Director, Deloitte Consulting

Andy Wiesenthal is a Director in the provider practice in the San Francisco office.  Before coming to the firm, he practiced pediatrics and pediatric infectious diseases for 35 years.  He is board certified in both and has published book chapters and articles on a wide range of clinical and health services topics.

Zika virus is much in the news lately,

Read more

The specialty pharmacy elephant

by George Van Antwerp, Senior Manager, Deloitte Consulting LLP

If you want to talk about growing health care costs in the US, specialty pharmaceuticals (i.e., high cost drugs used to treat conditions like cancer, rheumatoid arthritis, or Hepatitis C) is one topic which gets people excited for multiple reasons:

  1. Pharmacy spending in employer insurance benefits has ballooned up to 19 percent of total health care costs (excluding drug spending under the medical benefit);
Read more

Navigating the blizzard of health care regulation and legislation

by Harry Greenspun, MD, Director, Deloitte Center for Health Solutions, Deloitte Services LP

Well before the blizzard hit Washington, DC last week, we had plenty of warning. News channels had continuous coverage predicting record snowfalls, which sent people scurrying to grocery stores. For those unconvinced that the city could be paralyzed, a light dusting of snow that fell a few days before the big event turned their afternoon commute into mayhem.

Read more

Implications for the rise of AI in health care and patient engagement

by Dan Housman, Director, Deloitte Consulting LLP

Last year the movie Her was released in theaters featuring an Artificially Intelligent (AI) operating system able to relate and integrate herself into the main character’s life so much that he fell in love with her. With a year to reflect on this, and increasingly with an earpiece or headphones already in my ear from my phone or computer,

Read more

Why the Cadillac tax should (still) not be ignored

by Anne Phelps, Principal, US Health Care Regulatory Leader, Deloitte & Touche LLP

In late December 2015, as part of a bill to fund the federal government for 2016, Congress delayed the “Cadillac tax” – the tax on high-cost employer-sponsored coverage – for two years. As a result of the delay, which costs approximately $19.7 billion, the tax will apply in 2020, rather than the original Affordable Care Act (ACA) date of 2018 (see Top regulatory trends for 2016 in Life Sciences and Health Care for more information).

Read more

The insight-driven organization: A model for future competitive success

by Nitin Mittal, Principal, Deloitte Consulting LLP

Athletes often say that they need to look “within themselves” to focus intently on preparation and performance in order to achieve better results. It’s a strategy that frequently works for sports professionals, but it’s not something I’d recommend for players in the health care and life sciences sectors.

Looking inward – relying on internal operations,

Read more